Literature DB >> 33516167

Metabolic Syndrome Severity Score for Predicting Cardiovascular Events: A Nationwide Population-Based Study from Korea.

Yo Nam Jang1, Jun Hyeok Lee2, Jin Sil Moon2, Dae Ryong Kang3, Seong Yong Park4, Jerim Cho4, Jang-Young Kim5, Ji Hye Huh6.   

Abstract

BACKGROUND: Recently, a metabolic syndrome severity score (MS score) using a dataset of the Korea National Health and Nutrition Examination Surveys has been developed. We aimed to determine whether the newly developed score is a significant predictor of cardiovascular (CV) events among the Korean population.
METHODS: From the Korean National Health Insurance System, 2,541,364 (aged 40 to 59 years) subjects with no history of CV events (ischemic stroke or myocardial infarction [MI]), who underwent health examinations from 2009 to 2011 and were followed up until 2014 to 2017, were identified. Cox proportional hazard model was employed to investigate the association between MS score and CV events. Model performance of MS score for predicting CV events was compared to that of conventional metabolic syndrome diagnostic criteria (Adult Treatment Program III [ATP-III]) using the Akaike information criterion and the area under the receiver operating characteristic curve.
RESULTS: Over a median follow-up of 6 years, 15,762 cases of CV events were reported. MS score at baseline showed a linear association with incident CV events. In the multivariable-adjusted model, the hazard ratios (95% confidence intervals) comparing the highest versus lowest quartiles of MS score were 1.48 (1.36 to 1.60) for MI and 1.89 (1.74 to 2.05) for stroke. Model fitness and performance of the MS score in predicting CV events were superior to those of ATP-III.
CONCLUSION: The newly developed age- and sex-specific continuous MS score for the Korean population is an independent predictor of ischemic stroke and MI in Korean middle-aged adults even after adjusting for confounding factors.

Entities:  

Keywords:  Cardiovascular diseases; Metabolic syndrome; Myocardial infarction; Stroke

Year:  2021        PMID: 33516167     DOI: 10.4093/dmj.2020.0103

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  3 in total

1.  Triglyceride-Glucose Index for the Diagnosis of Metabolic Syndrome: A Cross-Sectional Study of 298,652 Individuals Receiving a Health Check-Up in China.

Authors:  Mingfei Jiang; Xiaoran Li; Huan Wu; Fan Su; Lei Cao; Xia Ren; Jian Hu; Grace Tatenda; Mingjia Cheng; Yufeng Wen
Journal:  Int J Endocrinol       Date:  2022-06-29       Impact factor: 2.803

2.  Optimal Low-Density Lipoprotein Cholesterol Levels in Adults Without Diabetes Mellitus: A Nationwide Population-Based Study Including More Than 4 Million Individuals From South Korea.

Authors:  Ji Hye Huh; Sang Wook Park; Tae-Hwa Go; Dae Ryong Kang; Sang-Hak Lee; Jang-Young Kim
Journal:  Front Cardiovasc Med       Date:  2022-01-20

3.  Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Pil Gyu Park; Jung Yoon Pyo; Sung Soo Ahn; Jason Jungsik Song; Yong-Beom Park; Ji Hye Huh; Sang-Won Lee
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.